Zoetis Inc. (FRA:ZOE)
124.08
+2.42 (1.99%)
At close: Sep 30, 2025
Zoetis Employees
Zoetis had 13,800 employees as of December 31, 2024. The number of employees decreased by 300 or -2.13% compared to the previous year.
Employees
13,800
Change (1Y)
-300
Growth (1Y)
-2.13%
Revenue / Employee
€579,082
Profits / Employee
€161,168
Market Cap
55.27B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13,800 | -300 | -2.13% |
Dec 31, 2023 | 14,100 | 300 | 2.17% |
Dec 31, 2022 | 13,800 | 1,700 | 14.05% |
Dec 31, 2021 | 12,100 | 800 | 7.08% |
Dec 31, 2020 | 11,300 | 700 | 6.60% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Rheinmetall AG | 28,539 |
Siemens Energy AG | 98,000 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Deutsche Bank Aktiengesellschaft | 89,753 |
Zoetis News
- 9 hours ago - Zoetis (ZTS) Gains FDA Nod for Innovative Livestock Parasite Treatment - GuruFocus
- 9 hours ago - Zoetis granted conditional approval of Dectomax-CA1 for parasitic infection in cattle - Seeking Alpha
- 11 hours ago - Zoetis Receives Conditional Approval for Dectomax-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle - Wallstreet:Online
- 11 hours ago - Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle - Business Wire
- 11 hours ago - Zoetis (ZTS) Gains Conditional FDA Approval for Cattle Treatment - GuruFocus
- 3 days ago - ZTS Quantitative Stock Analysis - Warren Buffett - Nasdaq
- 4 days ago - Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing - Nasdaq
- 4 days ago - Pet Pain For Investor Gain - Seeking Alpha